Product NDC: | 68180-317 |
Proprietary Name: | Imipramine Pamoate |
Non Proprietary Name: | Imipramine Pamoate |
Active Ingredient(s): | 150 mg/1 & nbsp; Imipramine Pamoate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68180-317 |
Labeler Name: | LUPIN PHARMACEUTICALS INC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090444 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100416 |
Package NDC: | 68180-317-06 |
Package Description: | 30 CAPSULE in 1 BOTTLE (68180-317-06) |
NDC Code | 68180-317-06 |
Proprietary Name | Imipramine Pamoate |
Package Description | 30 CAPSULE in 1 BOTTLE (68180-317-06) |
Product NDC | 68180-317 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Imipramine Pamoate |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20100416 |
Marketing Category Name | ANDA |
Labeler Name | LUPIN PHARMACEUTICALS INC |
Substance Name | IMIPRAMINE PAMOATE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Tricyclic Antidepressant [EPC] |